Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy
- 15 April 2001
- journal article
- clinical trial
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 218 (8), 1275-1280
- https://doi.org/10.2460/javma.2001.218.1275
Abstract
Objective—To determine the effect of the 5α-reductase inhibitor finasteride on prostatic diameter and volume, semen quality, and serum dihydrotestosterone (DHT) and testosterone concentrations in dogs with spontaneous benign prostatic hypertrophy (BPH). Design—Double-blind placebo-controlled trial. Animals—9 dogs with BPH. Procedure—Five dogs were treated with finasteride for 16 weeks (0.1 to 0.5 mg/kg [0.05 to 0.23 mg/lb] of body weight, PO, q 24 h); the other 4 received a placebo. Prostatic diameter, measured radiographically, prostatic volume, measured ultrasonographically, semen quality, and serum DHT and testosterone concentrations were evaluated before and during treatment. After receiving the placebo for 16 weeks, the 4 control dogs were treated with finasteride for 16 weeks, and evaluations were repeated. Results—Finasteride significantly decreased prostatic diameter (mean percentage decrease, 20%), prostatic volume (mean percentage decrease, 43%), and serum DHT concentration (mean percentage decrease, 58%). Finasteride decreased semen volume but did not adversely effect semen quality or serum testosterone concentration. No adverse effects were reported by owners of dogs in the study. Conclusions and Clinical Relevance—Results suggest that finasteride can be used to reduce prostatic size in dogs with BPH without adversely affecting semen quality or serum testosterone concentration. (J Am Vet Med Assoc 2001;218:1275–1280)Keywords
This publication has 25 references indexed in Scilit:
- Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled studyUrology, 1995
- Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: Effect of 5‐alpha reductase inhibitorsThe Prostate, 1995
- Comparison of the effects of new specific azasteroid inhibitors of steroid 5α-reductase on canine hyperplastic prostate: Suppression of prostatic DHT correlated with prostate regressionThe Prostate, 1995
- Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasterideEndocrinology, 1995
- STEROID 5α-REDUCTASE: TWO GENES/TWO ENZYMESAnnual Review of Biochemistry, 1994
- Effects of chronic oral administration of a selective 5α‐reductase inhibitor, finasteride, on the dog prostateThe Prostate, 1994
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991
- MEDROXYPROGESTERONE ACETATE AND REPRODUCTIVE PROCESSES IN MALE DOGSAustralian Veterinary Journal, 1979
- THE INFLUENCE OF OESTRADIOL ON THE METABOLISM OF ANDROGENS BY HUMAN PROSTATIC TISSUEJournal of Endocrinology, 1977